Stock-based compensation increased 50.1%
Stock-based compensation changed +50.1% from the comparable as-filed period.
$6.7M→$10.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →NTGR financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Receivables / revenue moved 571 bp higher
Receivables / revenue changed +571 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
84.95%→90.66%2 prior comparisons
SBC / revenue moved 203 bp higher
SBC / revenue changed +203 basis points from the comparable as-filed period.
3.91%→5.94%2 prior comparisons
Capex / revenue moved 121 bp lower
Capex / revenue changed -121 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.07%→0.86%2 prior comparisons
Free-cash-flow margin moved 378 bp lower
Free-cash-flow margin changed -378 basis points from the comparable as-filed period.
-3.11%→-6.89%2 prior comparisons
Operating cash-flow margin moved 499 bp lower
Operating cash-flow margin changed -499 basis points from the comparable as-filed period.
-1.04%→-6.03%2 prior comparisons
Operating margin moved 59 bp higher
Operating margin changed +59 basis points from the comparable as-filed period.
-5.59%→-5.01%2 prior comparisons
Current liabilities increased 5.0%
Current liabilities changed +5.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$243.1M→$255.4M4 prior comparisons
Inventory increased 11.2%
Inventory changed +11.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$157.3M→$174.9M4 prior comparisons
Operating income increased 11.5%
Operating income changed +11.5% from the comparable as-filed period.
-$9.5M→-$8.4M2 prior comparisons
Current assets decreased 9.3%
Current assets changed -9.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$698.7M→$633.7M4 prior comparisons
Revenue decreased 1.2%
Revenue changed -1.2% from the comparable as-filed period.
$170.5M→$168.6M2 prior comparisons
Trade receivables increased 5.5%
Trade receivables changed +5.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$144.9M→$152.8M4 prior comparisons
R&D / revenue moved 103 bp higher
R&D / revenue changed +103 basis points from the comparable as-filed period.
12.22%→13.25%2 prior comparisons
Cost of revenue decreased 5.4%
Cost of revenue changed -5.4% from the comparable as-filed period.
$106.6M→$100.8M2 prior comparisons
Research & development increased 7.1%
Research & development changed +7.1% from the comparable as-filed period.
$20.8M→$22.3M2 prior comparisons
Gross profit increased 6.0%
Gross profit changed +6.0% from the comparable as-filed period.
$64.0M→$67.8M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.